# Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

> **NCT05938699** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nicox Ophthalmics, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Open Angle Glaucoma

## Interventions

- **DRUG:** NCX 470
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05938699
- **Lead sponsor:** Nicox Ophthalmics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-12
- **Primary completion:** 2025-03-17
- **Final completion:** 2025-03-17
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05938699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05938699, "Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05938699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*